The Alpha Omega Cohort

A cohort of Dutch patients with a history of myocardial infarction

The Alpha Omega Cohort emerged from the Alpha Omega Trial, a 3-year intervention study of omega-3 fatty acids after myocardial infarction.
Read more about the study population
4837 patients
with history of myocardial infarction
60-80 years of age
most receiving state-of-the-art drugs

From trial to cohort

The Alpha Omega Trial was designed to examine whether major cardiovascular events could be prevented by low doses of omega-3 fatty acids (incorporated in margarines) in 4,837 Dutch patients with a history of myocardial infarction.

Patients were enrolled from 2002-2006 and the trial was completed in 2009. Follow-up of the Alpha Omega Cohort for cause-specific mortality is still ongoing.